IGEA works to improve patient’s Quality of Life developing and producing, from own original projects, innovative, effective and safe therapeutic systems for clinical practice. IGEA develops biophysical treatments in two main areas:
Orthopedics: to improve bone healing and joint preservation.
Oncology: to treat cancer. The Cliniporator® and the Cliniporator® VITAE are the most advanced electroporation technologies for the treatment of tumor nodules located to the skin, subcutaneous tissue, parenchyma and bone.
IGEA’s founders bought back the majority of Indaco’s shares in 2016.